The protective effects of hesperidin pretreatment on kidney and remote organs against renal ischemia-reperfusion injury.
Journal
European review for medical and pharmacological sciences
ISSN: 2284-0729
Titre abrégé: Eur Rev Med Pharmacol Sci
Pays: Italy
ID NLM: 9717360
Informations de publication
Date de publication:
04 2023
04 2023
Historique:
medline:
20
4
2023
entrez:
18
4
2023
pubmed:
19
4
2023
Statut:
ppublish
Résumé
As an antioxidant and anti-inflammatory agent, Hesperidin was investigated to prove whether it prevents damage to the kidney and lung tissues of rats undergoing renal ischemia-reperfusion injury. Four groups of rats were set, including eight subjects each as Group 1 (control), Group 2-RIR (renal ischemia reperfusion), Groups 3 and 4 as pretreatment groups (50 HES, 100 HES). According to our results, Hesperidin pretreatment improved the biochemical and histopathological parameters in kidney and lung tissues of rats with ischemia-reperfusion injury. Besides, a 100 mg/kg dose of Hesperidin was found to be more beneficial to the rats than 50 mg/kg. The study suggests that Hesperidin is protective against renal and lung tissues of rats that underwent ischemia-reperfusion injury.
Identifiants
pubmed: 37070880
doi: 10.26355/eurrev_202304_31911
pii:
doi:
Substances chimiques
Hesperidin
E750O06Y6O
Antioxidants
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM